Auctifer Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.79%
- Profit Growth 8.43%
- Ebitda 14.96%
- Net Worth 10.91%
- Total Assets 50.34%
About Auctifer Life Sciences
Auctifer Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 January 2017 (Eight years 20 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeevan Deodhar, Yogesh Kulkarni, and Sambhaji Pawar serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85300MH2017PTC289835
-
Company No.
289835
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Auctifer Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeevan Deodhar
|
Director | 05-May-2020 | Current |
|
Yogesh Kulkarni
|
Director | 04-Jul-2019 | Current |
|
Sambhaji Pawar
|
Director | 31-Mar-2022 | Current |
Financial Performance of Auctifer Life Sciences.
Auctifer Life Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.79% increase. The company also saw a slight improvement in profitability, with a 8.43% increase in profit. The company's net worth Soared by an impressive increase of 10.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auctifer Life Sciences?
Unlock access to Auctifer Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vatsal Ayurvedic Products Private LimitedSanjeevan Deodhar is a mutual person
-
Knowveda Lifetech Private Limited
Sanjeevan Deodhar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Auctifer Life Sciences?
Unlock and access historical data on people associated with Auctifer Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auctifer Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auctifer Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
